<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T02:47:52Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12052" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12052</identifier><datestamp>2026-10-18T21:13:17Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Can atherogenic indices and the triglyceride-glucose index be used to predict erectile dysfunction?</dc:title><dc:creator>Sambel, Murat</dc:creator><dc:creator>Erdogan, Abdullah</dc:creator><dc:creator>Caglayan, Volkan</dc:creator><dc:creator>Avci, Sinan</dc:creator><dc:creator>Kilic, Sahin</dc:creator><dc:creator>Yildiz, Halil Emre</dc:creator><dc:creator>Keskin, Ercument</dc:creator><dc:subject>atherogenic indices</dc:subject><dc:subject>endothelial dysfunction</dc:subject><dc:subject>erectile dysfunction</dc:subject><dc:subject>insulin resistance</dc:subject><dc:subject>triglyceride-glucose index</dc:subject><dc:subject>glucose</dc:subject><dc:subject>high density lipoprotein</dc:subject><dc:subject>low density lipoprotein</dc:subject><dc:subject>sex hormone binding globulin</dc:subject><dc:subject>testosterone</dc:subject><dc:subject>triacylglycerol</dc:subject><dc:subject>adult</dc:subject><dc:subject>Article</dc:subject><dc:subject>atherogenic index</dc:subject><dc:subject>cholesterol blood level</dc:subject><dc:subject>comparative study</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>correlation analysis</dc:subject><dc:subject>cross-sectional study</dc:subject><dc:subject>follow up</dc:subject><dc:subject>human</dc:subject><dc:subject>International Index of Erectile Function</dc:subject><dc:subject>lipid blood level</dc:subject><dc:subject>major clinical study</dc:subject><dc:subject>male</dc:subject><dc:subject>middle aged</dc:subject><dc:subject>penis artery</dc:subject><dc:description>Background: Atherosclerosis and insulin resistance play an important role in the development of erectile dysfunction (ED), and few studies have comprehensively evaluated more specific indicators like atherogenic indices and the triglyceride-glucose (TyG) index in the assessment of ED. Aim: This study aimed to reveal the role of atherogenic indices (atherogenic index of plasma [AIP], Castelli risk index-1/2 [CRI-1/2], and atherogenic coefficient [AC]) based on plasma lipid ratios, which have been used as more sensitive indicators of atherosclerosis in recent years, and the TyG index, a practical indicator of insulin resistance, in predicting vasculogenic ED. Methods: The study included a total of 199 patients who met the inclusion criteria and a total of 51 control subjects without ED complaints according to the International Index of Erectile Function (IIEF-5) scores (&gt;21) between May 2021 and October 2022. For all participants, the demographic and biochemical parameters were evaluated, and atherogenic indices, namely CRI-1 (total cholesterol/high-density lipoprotein [HDL]), CRI-2 (LDL/HDL) AIP [log10(triglycerides/HDL)], and AC (non-HDL/HDL), as well as the TyG index [Ln {fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2}] were calculated. Outcomes: The TyG index, which is an indicator of insulin resistance, and atherogenic indices such as CRI-1, AIP, and AC were significantly associated with ED, and especially AIP and the TyG index seem to be more important in the evaluation of ED. Results: According to the univariate analysis, the patient group had significantly higher CRI-1 (5.3 ± 1.4 vs 4.7 ± 1.3; P = .005), AIP (0.31 ± 0.26 vs 0.13 ± 0.2; P &lt; .001), AC (4.1 ± 1.4 vs 3.70 ± 1.2; P = .026), and TyG (9.16 ± 0.71 vs 8.77 ± 0.52; P &lt; .001) values compared with the control group. In the correlation analysis, a significant negative correlation was found between the AIP and TyG index and the IIEF-5 scores (r2 = 0.120, P &lt; .001 between AIP and IIEF-5; r2 = 0.091, P &lt; .001 between TyG index and IIEF-5). The multivariate analysis revealed AIP and the TyG index as independent predictive factors for ED. Clinical Implications: The use of atherogenic indices and TyG index in daily urology practice can help physicians in the diagnosis and follow-up of ED. Strengths and Limitations: The lack of sex hormone–binding globulin and free testosterone levels represents a limitation of our study. Another limitation is that the severity of ED was determined using the IIEF-5 scores, rather than a more objective method, such as penile artery ultrasound. Conclusion: Atherogenic indices and the TyG index can be used as inexpensive and practical markers to predict the severity of arteriogenic ED. © 2023 Elsevier B.V.. All rights reserved.</dc:description><dc:publisher>Oxford University Press</dc:publisher><dc:date>2023</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/12052</dc:identifier><dc:identifier>https://doi.org/10.1093/sexmed/qfad069</dc:identifier><dc:identifier>2050-1161</dc:identifier><dc:language>en</dc:language><dc:relation>Sexual Medicine</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/12052</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>